Cordlife Group Ltd
SGX:P8A

Watchlist Manager
Cordlife Group Ltd Logo
Cordlife Group Ltd
SGX:P8A
Watchlist
Price: 0.155 SGD -1.9% Market Closed
Market Cap: 39.7m SGD
Have any thoughts about
Cordlife Group Ltd?
Write Note

Cordlife Group Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cordlife Group Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cordlife Group Ltd
SGX:P8A
Cash from Operating Activities
-S$1.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Q & M Dental Group (Singapore) Ltd
SGX:QC7
Cash from Operating Activities
S$33.3m
CAGR 3-Years
12%
CAGR 5-Years
21%
CAGR 10-Years
23%
Healthway Medical Corporation Ltd
SGX:5NG
Cash from Operating Activities
S$16.3m
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
13%
T
Talkmed Group Ltd
SGX:5G3
Cash from Operating Activities
S$34.3m
CAGR 3-Years
13%
CAGR 5-Years
0%
CAGR 10-Years
N/A
HC Surgical Specialists Ltd
SGX:1B1
Cash from Operating Activities
S$6.3m
CAGR 3-Years
-16%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
EUDA Health Holdings Ltd
NASDAQ:EUDA
Cash from Operating Activities
-$2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Cordlife Group Ltd
Glance View

Market Cap
39.7m SGD
Industry
Health Care

Cordlife Group Ltd. is an investment holding company, which engages in the provision of cord blood and cord lining banking services. The Company’s segments include Banking and Diagnostic. The Banking segment comprises the banking of samples, such as cord blood, cord lining and cord tissue. The Diagnostic segment comprises Metascreen, which is a metabolic screening test specially designed for newborn babies, a non-invasive prenatal testing service, and Eyescreen, a noninvasive pediatric eye-screening service. The cord blood and cord lining are collected, processed and stored in the various laboratories in the regions that the Company operates in. The firm offers a range of diagnostics services for the family, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.

P8A Intrinsic Value
0.263 SGD
Undervaluation 41%
Intrinsic Value
Price

See Also

What is Cordlife Group Ltd's Cash from Operating Activities?
Cash from Operating Activities
-1.6m SGD

Based on the financial report for Jun 30, 2024, Cordlife Group Ltd's Cash from Operating Activities amounts to -1.6m SGD.

Back to Top